The Therapeutic Fraud Prevention Act of 2025 would prohibit the commercial practice of conversion therapy — treatments that claim to change someone's sexual orientation or gender identity. The bill defines conversion therapy as any paid practice or service designed to alter sexual orientation or gender identity, while excluding legitimate medical support for people undergoing gender transitions and counseling that focuses on acceptance and coping. The legislation would be enforced by the Federal Trade Commission as an unfair and deceptive trade practice, with the FTC, U.S. Attorney General, and state attorneys general all authorized to bring civil enforcement actions against violators. The bill is based on the congressional finding that major professional organizations have determined conversion therapy is ineffective and harmful, potentially contributing to depression, self-harm, and suicide. The bill contains no specific funding or implementation timeline beyond authorizing enforcement agencies to pursue violations through existing legal mechanisms.